Electrophysiologic effects of a new antiarrhythmic agent, recainam, on isolated canine and rabbit myocardial fibers.

[1]  D C Harrison,et al.  Antiarrhythmic drug classification: new science and practical applications. , 1985, The American journal of cardiology.

[2]  E. Carmeliet.  Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. , 1985, The Journal of pharmacology and experimental therapeutics.

[3]  L. D. Davis,et al.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers. , 1985, Journal of the American College of Cardiology.

[4]  C. Starmer,et al.  Antiarrhythmic drug action. Blockade of the inward sodium current. , 1984, Circulation research.

[5]  J. Mason,et al.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. , 1984, Circulation research.

[6]  L. Horowitz,et al.  Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. , 1984, The American journal of cardiology.

[7]  T. Campbell.  Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. , 1983, Cardiovascular research.

[8]  T. Campbell,et al.  Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. , 1983, Cardiovascular research.

[9]  D. Zipes,et al.  Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers. , 1982, The Journal of pharmacology and experimental therapeutics.

[10]  A. Mugelli,et al.  Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac Preparations , 1981, Journal of cardiovascular pharmacology.

[11]  K. Courtney.  Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. , 1980, Journal of molecular and cellular cardiology.

[12]  B. Katzung,et al.  Test of a Model of Antiarrhythmic Drug Action Effects of Quinidine and Lidocaine on Myocardial Conduction , 1980, Circulation.

[13]  B. Singh,et al.  Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. , 1978, Pharmacological reviews.

[14]  P F Cranefield,et al.  Action potentials, afterpotentials, and arrhythmias. , 1977, Circulation research.

[15]  B. Singh,et al.  The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle , 1970, British journal of pharmacology.

[16]  B. Singh,et al.  A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 , 1970, British journal of pharmacology.

[17]  J. L. Bergey,et al.  Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362). , 1983, Arzneimittel-Forschung.

[18]  E.M.Vaughan Williams D.M. D.Sc..  Classification of antidysrhythmic drugs. , 1975 .